We’re very excited to be officially launching ATIC at the upcoming ADC 2022 in Brisbane.

Attending ADC? Here are the details you will need:

What: The Australian Type 1 Diabetes Immunotherapy Collaborative, a JDRF-funded clinical trials network.

When: Wed 10 Aug, 10am-12pm, ADS Basic Science Symposium 5: ‘Frontiers in Type 1 Diabetes’

Where: Great Hall 3 – Brisbane Convention & Exhibition Centre

Speakers

Associate Professor John Wentworth, ATIC Lead Investigator

Introduction by Dr Dorota Pawlak, Chief Scientific Officer, JDRF

With guest appearances by: Professor Chantal Mathieu (INNODIA lead), Professor Colin Dayan (T1DUK), Professor Kevan Herold (TrialNet) and Dr Francisco Leon (Provention Bio).